Back to Screener
CORESTEMCHEMON
166480KOSDAQ🇰🇷Healthcare · Biotechnology
₩2,300▼ 12.71%
Last updated: 1m ago
52-Week Range
₩1,014
₩4,310
Company Overview
CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral scle
Valuation
PER (TTM)—
Forward PER—
PBR2.30
PSR3.77
EV/EBITDA-5.68
Market Cap$72.49B
Profitability
ROE-39.91%
ROA-14.97%
Net Margin-64.20%
Operating Margin-207.99%
Growth & Stability
Revenue Growth-56.70%
Earnings Growth—
Debt-to-Equity129.0
Current Ratio0.27
Beta1.20
Dividends
Dividend Yield—
Payout Ratio0.0%
Trading Info
Prev Close₩2,635
Volume62K
Avg Volume1.0M